The stock of Chembio Diagnostics Inc (NASDAQ:CEMI) closed at $7.70 gaining 0.65% in yesterday’s trading session. Chembio Diagnostics has already completed its most recent clinical trial that targeted evaluating its DPP® HIV-Syphilis System. At the moment, it has plans underway to file for a Pre-Market Approval (PMA) submission. That will of course be with the Food and […]
Chembio Diagnostics Inc
Recent Stories
Amazon.com, Inc (NASDAQ:AMZN) May Be Considering Buying WWE Fully
Twitter Inc (NYSE:TWTR) Speaks Out On Facebook, Inc (NASDAQ:FB) Hacked Accounts
Apple Inc (NASDAQ:AAPL) To Pay A Hefty Fine After Slowing Down Older Devices
Preparing for Green Wave 3.0: The Shopping List (HEMP, CGRW, GTEH, CGC, TLRY, MJNA)